I know nothing, friend, that's just my opinion. The fall and fall of ANR can be attributed to the inability to define an effective pharmacological pathway for bromelain - a well characterised, generic enzyme with limited/low margin capacity. That's an opinion too.
If SUD was in the lipstick game, they should be teaming up with supermodels and superstars. Not pigs.
ARTMIST, page-57
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $126.0M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.0¢ | $54.30K | 436.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 460793 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 142891 | 6 |
View Market Depth
| Last trade - 15.14pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
-0.005 ( 4.00 %) |
||||
| Open | High | Low | Volume | ||
| 12.8¢ | 13.0¢ | 12.0¢ | 198470 | ||
| Last updated 14.42pm 08/05/2024 ? | |||||
| ALA (ASX) Chart |